Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN16538701) titled 'Combined treatment of heart failure after coronary heart disease' on May 20.
Study Type: Interventional
Study Design:
Single center randomized controlled trial (Treatment)
Primary Sponsor: Tianshui Hospital of Traditional Chinese Medicine
Condition:
Combined treatment of heart failure after coronary heart disease
Circulatory System
Intervention:
106 patients with coronary heart disease and heart failure were randomly divided into control group and experimental group by simple random grouping method, 53 cases in each group.The control group was treated with Sacubitril/valsartan orally, and the experimental gr...